| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | CEO | Director +1 more
3 companies
Tarriff Scott is a 10% Owner at EAGLE PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $223K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 21,619 | $13.84 | $299,309.28 | -1.9% | |
| Oct 3, 2023 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 20,245 | $14.82 | $300,026.47 | -1.2% | |
| May 16, 2023 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 15,000 | $19.98 | $299,700.00 | -2.5% | |
| May 15, 2023 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 45,000 | $20.68 | $930,656.37 | -0.6% | |
| Apr 1, 2019 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 24,975 | $50.15 | $1,252,496.25 | -1.6% | |
| Mar 1, 2019 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 24,428 | $51.17 | $1,250,014.68 | -0.8% | |
| Feb 1, 2019 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 30,085 | $41.54 | $1,249,831.20 | -1.0% | |
| Jan 3, 2019 | EGRX Eagle Pharmaceuticals, Inc. | CEO | Sell | 31,569 | $39.49 | $1,246,763.02 | -0.4% | |
| Apr 1, 2016 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 30,765 | $40.63 | $1,249,981.95 | -2.2% | |
| Mar 1, 2016 | EGRX Eagle Pharmaceuticals, Inc. | President And CEO | Sell | 19,780 | $63.20 | $1,250,027.96 | -0.7% |